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Cysticercosis is a systemic illness caused by Taenia Solium larvae dissemination.1
Although it can occur in almost any tissue, neurocysticercosis (NCC) is the most
clinically important manifestation and may present with dramatic findings due to
skull and spinal canal confines.2 Though NCC is not rare in Korea,3 spinal
neurocysticercosis (SNCC) is (1.5%).3 Its rarity has been explained by the fact
that intracranial cysticerci do not pass through the subarachnoid space at the
cervical level due to its size.1 Although cases of SNCC have previously been
reported, there has been no report of whole spinal canal involvement requiring
multiple operations. We present such a rare case.
A 45-year-old Korean male presented with a 3-month history of progressive
lower limb weakness and voiding difficulty. Fifteen years ago, he had been
diagnosed with intracranial cysticercosis. At that time, brain magnetic resonance
imaging (MRI) revealed mild hydrocephalus and focal meningitis in the left
cerebello-pontine and ambient cistern. A enzyme-linked immunosorbent assay of
hos cerebrospinal fluid test confirmed cysticercosis,4,5 and the patient completed 2
cycles of oral praziquantel (PZQ; 50 mg/kg per day in 3 divided doses for 14
days)6 and carbamazepine (CMZ; 400 mg per day in 2 divided doses daily) for
seizure prophylaxis. He was well until severe headache recurred 10 years later.
Brain MRI then revealed slightly aggravated hydroce-phalus. Reactivated NCC
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was suspected as the patient complained of severe headache,
CSF examination showed inflammation, and a CSF
ELISA test confirmed cysticercosis. The patient received 3
cycles of albendazole (ABZ; 15 mg/kg per day in 3
divided doses for 7 days), and his antiepileptic was changed
to valproic acid (VPA; 900 mg per day in 3 divided doses
daily). The patient recovered well until this current presen-
tation. Neurological examination revealed Grade 3 lower
limb motor weakness, no sensory abnormality, and alert
mental state. Compared with prior MRI results, brain MRI
revealed unchanged hydrocephalus and no evidence of
cyst or meningitis. However, T2-weighted MR images of
the spine demonstrated multiple cysts compressing the
spinal cord from C1 to L1 (Fig. 1). The patient underwent
surgical removal. Laminectomy from C1 to C2, T1 to T3,
and T11 to L1 was performed. Linear incision was made
on the dura. Arachnoiditis was noticed focally. Several
white encapsulated cysts containing clear fluid adhered to
the arachnoid membrane and were dissected with difficulty,
but the rest was easily removed. Histopathological exa-
mination confirmed cysticercosis. Albendazole (ABZ; 15
mg/kg per day in 3 divided doses for 14 days) was pres-
cribed postoperatively. The patient improved enough to
ambulate with a walker and regained urinary function. 
Cysticercosis is the most common parasitic disease affect-
ing the central nervous system.1 SNCC is rare compared
with intracranial NCC, and its incidence is known to be 0.7
to 5.85%.7 Low incidence of SNCC is explained by the
“sieve effect.”1 The majority of cysticerci cannot pass
through the subarachnoid space at the cervical level due to
its size and the physiological sieve.1 CSF reflux at the
craniovertebral junction, which propels floating cysts back
into the intracranial space rather than the spinal canal, is an
another possible reason of why SNCC is rare. On the other
hand, there are several possible mechanisms of cysticer-
cosis spinal invasion. 1) Ventricular cysticerci pass through
the Magendie or Luschka foramen, and migrate via gravity
through the subarachnoid space to inoculate the spinal
cord.1,7 The subarachnoid form is explained by this me-
chanism. The subarachnoid form usually occurs at the
cervical level, but our present case demonstrated that it can
go as far as the cauda equina. 2) Hematogenous spread has
been regarded as the invading mode of the intramedullary
form. Spinal blood flow is richest at the thoracic level,
which is the most common level for the intramedullary
form.8 3) Intraventricular hypertension enables migration
through a dilated ependymal canal into the spinal cord. It
also explains the invading mode of the intramedullary
form.1 Besides, there are several prodromal conditions that
make cysticercosis readily invade the spinal contents.
These include NCC-related hydrocephalus and/or menin-
gitis, and use of antiepileptics and anithelminithics. SNCC
occurs in patients with a prior diagnosis of intracranial
NCC in approximately 75% of cases; direct extension of
intracranial NCC is implied as the source.1 Antiepileptic
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Fig. 1. T2-weighted MR images of the whole spine, which demonstrate cysts
located at the anterior subarachnoid space of T1-2 and posterior arachnoid
space of C2, T5-T7, L1, and L2. Increased signal intensity, which indicates edema
of the spinal cord, is noted at the level of T2 through T4 and T9 to T10 (arrows).
drugs, such as carbamazepine and phenytoin, can alter
immune function, and therefore, affect susceptibility to
parasitic infestation. Although a recent randomized con-
trolled trial demonstrated the benefit of antihelminthic
therapy in patients harboring viable cysts within the brain
parenchyma, it is thought to increase inflammation because
of cyst involution, leading to worsening clinical states,
which might accelerate dissemination of other viable
cysticerci.9,10 The long term prognosis of neurocysticercosis
is still not satisfactory.3,6,10 Our patient had a long history of
intracranial NCC with hydrocephalus and meningitis. In
addition, he had long term administration of antihelminthic
and antiepileptic drugs. These are thought to be the causa-
tive factors of extensive spinal involvement in our patient.
Although the subarachnoid form has been frequently
reported, there is no previous report to document SNCC
involving the whole spinal canal. This case demonstrates a
serious manifestation and successful surgical management
of SNCC secondary to intracranial NCC.
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